New Enterprise Associates 14, L.P. 13D and 13G filings for Mersana Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-12-10 1:17 pm Sale |
2020-12-01 | 13D | Mersana Therapeutics, Inc. MRSN |
New Enterprise Associates 14, L.P. | 0 0.000% |
-3,961,232 (Position Closed) |
Filing |
| 2020-11-19 1:29 pm Sale |
2020-11-09 | 13D | Mersana Therapeutics, Inc. MRSN |
New Enterprise Associates 14, L.P. | 3,961,232 5.800% |
-2,001,882 (-33.57%) |
Filing |
| 2020-09-21 7:02 pm Sale |
2020-09-14 | 13D | Mersana Therapeutics, Inc. MRSN |
New Enterprise Associates 14, L.P. | 5,963,114 8.700% |
-1,998,798 (-25.10%) |
Filing |